Labcorp Drug Development Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • Labcorp Drug Development's estimated annual revenue is currently $750M per year.(i)
  • Labcorp Drug Development's estimated revenue per employee is $80,394

Employee Data

  • Labcorp Drug Development has 9329 Employees.(i)
  • Labcorp Drug Development grew their employee count by -32% last year.

Labcorp Drug Development's People

NameTitleEmail/Phone
1
Executive Director, Business Development Early Development (Europe)Reveal Email/Phone
2
Executive Director, Business DevelopmentReveal Email/Phone
3
Executive Director Business DevelopmentReveal Email/Phone
4
VP - Global Client DeliveryReveal Email/Phone
5
VP, HR Partnering Clinical Trials Testing Solutions & Early DevelopmentReveal Email/Phone
6
Head DepartmentReveal Email/Phone
7
SVPReveal Email/Phone
8
Head Sample Management and ArchivesReveal Email/Phone
9
VP, Global Regulatory Compliance & Quality Assurance - Central Laboratory ServicesReveal Email/Phone
10
Security OfficerReveal Email/Phone

What Is Labcorp Drug Development?

keywords:N/A

N/A

Total Funding

9329

Number of Employees

$750M

Revenue (est)

-32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Labcorp Drug Development News

2022-04-20 - Labcorp beefs up at-home testing options with Getlabs' on ...

We actively use our QIAGEN biomedical knowledge graph in drug discovery projects in collaboration with industry partners and develop new...

2022-04-17 - Labcorp is teaming up with Xcell to expedite CGT development

The diagnostics and drug development company, Labcorp, is partnering with San Francisco based, Xcell Biosciences, to advance efforts to help...

2022-03-30 - Labcorp Renews Strategic Partnership with Medidata to ...

Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC (electronic data capture),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2353.2M93387%N/A
#2
$750M94856%N/A
#3
$4371.2M9607-8%N/A
#4
$3648.8M96535%N/A
#5
N/A9716-2%N/A